Suspecting that deconditioning might be contributing to his muscle soreness, columnist Kylene Henderson's husband, Donnie, is ...

Lower activity of a gene called ZNF331 may help identify obstructive sleep apnea (OSA), marked by repeated stops and starts in breathing during sleep, in people with idiopathic pulmonary fibrosis (IPF ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google As my regular readers may remember, I am prescribed supplemental ...

Raising awareness can take many forms, including education. September’s Pulmonary Fibrosis Awareness Month (PFAM) is an opportunity to educate not only the pulmonary fibrosis (PF) and interstitial ...

What is Esbriet for idiopathic pulmonary fibrosis? Esbriet (pirfenidone) is an approved oral medication that’s used to slow the decline of lung function in people with idiopathic pulmonary fibrosis ...

Taking oral dietary supplements of epigallocatechin-3-gallate (EGCG) — an antioxidant in green tea — may stop and reverse the pro-fibrotic (scarring) state of the lungs of people with idiopathic ...

The oral therapy Jascayd (nerandomilast) has been approved in the European Union for adults with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). The marketing ...

The U.S. Food and Drug Administration (FDA) will decide by early next year whether or not to expand its approval of nebulized Tyvaso (treprostinil) — an inhaled treatment for people with certain lung ...

Trevi Therapeutics plans to launch two pivotal Phase 3 clinical trials to continue testing Haduvio (nalbuphine extended-release) as a treatment for people with idiopathic pulmonary fibrosis (IPF) who ...

There is currently no cure for pulmonary fibrosis (PF). However, medication and other treatment options can help improve patients’ quality of life, ease symptoms, and slow the disease’s progression.

The Pulmonary Fibrosis Foundation (PFF), an advocacy group dedicated to advancing care for people with pulmonary fibrosis, has added two new members to its board of directors. Both new board members ...